Bristol-Myers Squibb (BMY) Tops Q4 EPS by 1c
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $48.30 +0.96%
EPS Growth %: -21.5%
Financial Fact:
Cost of products sold: 1.31B
Today's EPS Names:
ESCA, LICT, NKSH, More
EPS Growth %: -21.5%
Financial Fact:
Cost of products sold: 1.31B
Today's EPS Names:
ESCA, LICT, NKSH, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q4 EPS of $1.83, $0.01 better than the analyst estimate of $1.82. Revenue for the quarter came in at $12 billion versus the consensus estimate of $12.12 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2022 EPS of $7.65-$7.95.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BayCom Corp (BCML) Misses Q1 EPS by 4c
- Marten Transport (MRTN) Misses Q1 EPS by 2c
- Community West Bancshares (CWBC) Tops Q1 EPS by 7c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
